Abstract:Background. Limited studies and observations conducted on a too small number of patients prevent determining the actual clinical utility of pulmonary contrast-enhanced ultrasound (CEUS). The aim of the present study was to examine the efficacy of contrast enhancement (CE) arrival time (AT) and other dynamic CEUS findings for differentiating between malignant and benign peripheral lung lesions. Methods. 317 inpatients and outpatients (215 men, 102 women; mean age: 52 years) with peripheral pulmonary lesions were included in the study and underwent pulmonary CEUS. Patients were examined in a sitting position after receiving an intravenous injection of 4.8 mL of sulfur hexafluoride microbubbles stabilized by a phospholipid shell as ultrasound contrast agent (SonoVue—Bracco; Milan, Italy). Each lesion was observed for at least 5 min in real-time and the following temporal characteristics of enhancement were detected: the arrival time (AT) of microbubbles in the target lesion; the enhancement pattern; the wash-out time (WOT) of microbubbles. Results were then compared in light of the definitive diagnosis of community acquired pneumonia (CAP) or malignancies, which was not known at the time of CEUS examination. All malignant cases were diagnosed by histological results, while pneumonia was diagnosed on the basis of clinical and radiological follow-up, laboratory findings and, in some cases, histology. Results. CE AT has not been shown to differ between benign and malignant peripheral pulmonary lesions. The overall diagnostic accuracy and sensibility of a CE AT cut-off value < 10 s in discriminating benign lesions were low (diagnostic accuracy: 47.6%; sensibility: 5.3%). Poor results were also obtained in the sub-analysis of small (mean diameter 3 cm) lesions. No differences were recorded in the type of CE pattern showed between benign and malignant peripheral pulmonary lesions. In benign lesions we observed a higher frequency of delayed CE wash-out time (WOT) > 300 s. Anyhow, a CE WOT cut-off value > 300 s showed low diagnostic accuracy (53.6%) and sensibility (16.5%) in discriminating between pneumonias and malignancies. Similar results were also obtained in the sub-analysis by lesion size. Squamous cell carcinomas showed a more delayed CE AT compared to other histopathology subtypes. However, such a difference was statistically significant with undifferentiated lung carcinomas. Conclusions. Due to an overlap of CEUS timings and patterns, dynamic CEUS parameters cannot effectively differentiate between benign and malignant peripheral pulmonary lesions. Chest CT remains the gold standard for lesion characterization and the eventual identification of other pneumonic non-subpleural localizations. Furthermore, in the case of malignancy, a chest CT is always needed for staging purposes.

Contrast-enhanced ultrasound of pulmonary carcinoma:a preliminary study

Identification Value of Contrast-Enhanced Sonography on Peripheral Pulmonary Cancer

Analysis of Contrast Enhanced Ultrasound in Differential Diagnosis of Focal Organizing Pneumonia and Primary Lung Cancer

The application of contrast enhanced ultrasound for core needle biopsy of subpleural pulmonary lesions: retrospective analysis in 92 patients

Value of Contrast-Enhanced Ultrasound and Enhancement Patterns in the Diagnosis of Adrenal Tumors

Enhancement Patterns Of Gastric Carcinoma On Contrast-Enhanced Ultrasonography: Relationship With Clinicopathological Features

[Enhancement Pattern of Peripheral Lung Carcinoma:Comparison Between Contrast-Enhanced Ultrasonography and Contrast-Enhanced Computed Tomography].

Clinical Application of Contrast-Enhanced Ultrasonography in Central Lung Cancer with Obstructive Atelectasis

Contrast-enhanced Ultrasound of Intrahepatic Cholangiocarcinoma: Correlation with Pathological Examination

Contrast Enhanced Ultrasound Features and Pathology Foundation of Intrahepatic Cholangiocarcinoma

Enhancement Patterns of Intrahepatic Cholangiocarcinoma: Comparison Between Contrast-Enhanced Ultrasound and Contrast-Enhanced CT.

Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time

Role of Contrast-Enhanced Ultrasound in Pulmonary Lesions: 5-Year Experience at a Single Center

Peripheral Intrahepaitc Cholangiocarcinoma: Comparison of Two-Phased Contrast Enhanced CT and Contrast Enhanced Ultrasound

The Role of Quantitative Analysis of Contrast-Enhanced Ultrasound Combined with Tumor Marker in the Diagnosis of Peripheral Pulmonary Lesions

Application Value of Contrast-Enhanced Ultrasound in the Diagnosis and Puncture Biopsy of Lung Peripheral and Pleural Mass Lesions

Application of contrast enhanced ultrasound combined biopsy in qualitative diagnosis of peripheral pulmonary lesions

Contrast-enhanced ultrasound in differential diagnosis of benign and malignant focal liver lesions in 54 cases

Correlation Between Enhancement Pattern of Hepatocellular Carcinoma on Real-Time Contrast-Enhanced Ultrasound and Tumour Cellular Differentiation on Histopathology

Contrast enhanced ultrasonography in study on enhancement patterns of renal masses

The Value of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Central Lung Cancer with Obstructive Atelectasis